home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Laboratory Corp American Holdings (NY:LH)

254.46 +1.31 (+0.52%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Laboratory Corp American Holdings

< Previous 1 2 3 4 Next >

Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp

December 02, 2025

From Community Health Systems, Inc.

Via Business Wire

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

July 22, 2025

From Community Health Systems, Inc.

Via Business Wire

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

June 12, 2025

Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies

From Predictive Oncology Inc.

Via GlobeNewswire

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

November 04, 2024

From Praia Health

Via Business Wire

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

October 16, 2024

From NOWDiagnostics, Inc.

Via Business Wire

Is This Telehealth Stock a Buy After the Recent Pullback?

July 19, 2024

Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.

Via MarketBeat

Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX

April 30, 2024

Via AB Newswire

Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp

April 01, 2024

From Xcell Biosciences Inc.

Via Business Wire

LifeMD Shares Come Back to Life on GLP-1 Business Growth

March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024

Via MarketBeat

Laboratory Corp. of America Holdings (NYSE: LH) Records 52-Week High Tuesday Morning

January 02, 2024

Via Investor Brand Network

LifeMD expands telehealth GLP-1weight-loss service with Medifast

December 19, 2023

LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing

Via MarketBeat

2 aerospace stocks are ready to take flight on the next leg up

December 18, 2023

The aerospace sector has been red hot in 2023; here are two surging aerospace stocks with the potential to reach even higher altitudes

Via MarketBeat

Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors

August 08, 2023

From Singular Genomics Systems, Inc.

Via GlobeNewswire

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

July 24, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster

July 03, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Exact Sciences Serves Investors Exactly What They Wished For

May 15, 2023

Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The

Via MarketBeat

Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking

February 22, 2023

From Labcorp

Via Business Wire

Labcorp Announces 2022 Fourth Quarter and Full-Year Results

February 16, 2023

From Labcorp

Via Business Wire

Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea

February 09, 2023

From Labcorp

Via Business Wire

Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023

January 18, 2023

From Labcorp

Via Business Wire

Labcorp Declares Quarterly Dividend

January 12, 2023

From Labcorp

Via Business Wire

Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit

January 05, 2023

From Labcorp

Via Business Wire

Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Labcorp

Via Business Wire

Labcorp Opens New Los Angeles Based Laboratory

December 08, 2022

From Labcorp

Via Business Wire

Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference

October 31, 2022

From Labcorp

Via Business Wire

Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio

October 31, 2022

Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.

Via MarketBeat

Labcorp Announces 2022 Third Quarter Results

October 27, 2022

From Labcorp

Via Business Wire

Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board of Directors

October 13, 2022

From Labcorp

Via Business Wire

Labcorp Declares Quarterly Dividend

October 12, 2022

From Labcorp

Via Business Wire

Labcorp Establishes Comprehensive Laboratory Relationship With Ascension

October 03, 2022

From Labcorp

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com